Hyperion Therapeutics Inc (NASDAQ:HPTX)

45.95
Delayed Data
As of Apr 27
 -0.02 / -0.04%
Today’s Change
20.23
Today|||52-Week Range
46.96
+91.46%
Year-to-Date

Today’s Trading

Previous close45.97
Today’s open45.97
Day’s range-- - --
Volume228,825
Average volume (3 months)529,047
Market cap$955.0M
Dividend yield--
Data as of 04/27/2015

Growth & Valuation

Earnings growth (last year)-138.75%
Earnings growth (this year)+349.77%
Earnings growth (next 5 years)--
Revenue growth (last year)+169.13%
P/E ratioNM
Price/Sales4.33
Price/Book7.25

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-1.40-5.58%
SCMPSucampo Pharmaceutic...-1.58-7.49%
OREXOrexigen Therapeutic...-0.41-5.57%
OMEROmeros Corp-1.18-4.85%
Data as of 04/27/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.23
Annual revenue (last year)$113.6M
Annual profit (last year)-$6.3M
Net profit margin-5.51%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Donald J. Santel
Chief Financial Officer &
Senior Vice President
Jeffrey S. Farrow
Corporate headquarters
Brisbane, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers